After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CVAC belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of CureVac N.V is $708.81M. A total of 0.76 million shares were traded on the day, compared to an average of 826.49K shares.
In the most recent transaction, Myriam Mendila bought 17,839 shares of CVAC for 4.93 per share on Jan 07 ’25. In a previous transaction on Jan 07 ’25, Pierre Kemula bought 51,523 shares at 4.93 per share.
Among the insiders who bought shares, Alexander Zehnder acquired of 26,104 shares on Jan 07 ’25 at a per-share price of $4.93. In another insider transaction, Malte Greune bought 21,976 shares at $4.93 per share on Jan 07 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for CVAC in the last 3 months, the mean price target is $6.53 with high estimates of $15.42 and low estimates of $2.36. In terms of 52-week highs and lows, CVAC has a high of $5.28 and a low of $2.21.
As of this writing, CVAC has an earnings estimate of -$0.12 per share for the current quarter. EPS was calculated based on a consensus of 2.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.12.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CVAC’s latest balance sheet shows that the firm has $816.11M in Cash & Short Term Investments as of fiscal 2021. There were $28.89M in debt and $357.73M in liabilities at the time. Its Book Value Per Share was $3.61, while its Total Shareholder’s Equity was $688.48M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CVAC is Buy with a score of 3.50.
